|
 |
|
|
|||
 |
 
  
|
 |
|
Jan. 7, 2013 Brakke Consulting reports: Bayer HealthCare LLC announced that it has received the necessary regulatory approvals to complete the acquisition of the U.S.-based animal health business of Teva Pharmaceutical Industries Ltd. Bayer will pay up to $145 million following the achievement of successful manufacturing and sales targets. The transaction includes a manufacturing site in St. Joseph, Missouri and nearly 300 employees. Tweet |
|
|
|
|
|
|
|
|
 |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
